About: Experience with Temporary Centrifugal Pump Bi-ventricular Assist Device for Pediatric Acute Heart Failure: Comparison with ECMO

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Experience with Temporary Centrifugal Pump Bi-ventricular Assist Device for Pediatric Acute Heart Failure: Comparison with ECMO Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	Experience with Temporary Centrifugal Pump Bi-ventricular Assist Device for Pediatric Acute Heart Failure: Comparison with ECMO
Creator	Lim, Jae Kwon, Hye Bae, Eun Mi, · Gi, · Jeong, · Kim, Beom Kim, Woong-Han Kwak, Jae Lee, Ryul Min, Jooncheol Song, Kyung
topic	covid:cf4862c0fda8f258eb9188acbd4cd13afd5222e6#this
source	PMC
abstract	Though ventricular assist devices (VADs) are an important treatment option for acute heart failure, an extracorporeal membrane oxygenator (ECMO) is usually used in pediatric patients for several reasons. However, a temporary centrifugal pump-based Bi-VAD might have clinical advantages versus ECMO or implantable VADs. From January 2000 to July 2018, we retrospectively reviewed 36 pediatric patients who required mechanical circulatory support (MCS) for acute heart failure. Cases with postoperative MCS were excluded. Since 2016, we have tried to immediately add a right VAD rather than ECMO, when the patients begin to present features of right heart failure after left VAD support started in cases that the patients’ respiratory function did not require an oxygenator. Original diagnoses included dilated cardiomyopathy (n = 18), myocarditis (n = 11), and others (n = 7). Eleven patients were supported by Bi-VAD, and 25 patients were supported by ECMO; of these. Four patients were successfully weaned from VAD, and 10 patients were weaned from ECMO. Eleven patients underwent heart transplantation. Overall, we have 15 (41.7%) early mortalities. There were no significant differences in early mortality, morbidity, and weaning rate between the Bi-VAD group and the ECMO group. During the support, patients with Bi-VADs significantly required fewer platelets and showed less hemolysis than ECMO patients. Patients with myocarditis were successfully weaned from Bi-VAD support and bridged to transplantation thereafter. A temporary centrifugal pump-based Bi-VAD was clinically comparable to ECMO for pediatric patients with acceptable pulmonary function.
has issue date	2020-08-27(xsd:dateTime)
bibo:doi	10.1007/s00246-020-02412-0
bibo:pmid	32856126
has license	no-cc
sha1sum (hex)	cf4862c0fda8f258eb9188acbd4cd13afd5222e6
schema:url	https://doi.org/10.1007/s00246-020-02412-0
resource representing a document's title	Experience with Temporary Centrifugal Pump Bi-ventricular Assist Device for Pediatric Acute Heart Failure: Comparison with ECMO
has PubMed Central identifier	PMC7451784
has PubMed identifier	32856126
schema:publication	Pediatr Cardiol
resource representing a document's body	covid:cf4862c0fda8f258eb9188acbd4cd13afd5222e6#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/cf4862c0fda8f258eb9188acbd4cd13afd5222e6
is schema:about of	named entity 'heart transplantation' named entity 'ventricular assist devices' named entity 'circulatory support' named entity 'ECMO' named entity 'Overall' named entity 'ACCEPTABLE' named entity 'REVIEWED' named entity 'MECHANICAL CIRCULATORY SUPPORT' named entity 'USUALLY' named entity 'CASES' named entity '2000' named entity 'BASED' named entity 'PULMONARY FUNCTION' named entity 'USED' named entity 'PRESENT' named entity 'MORTALITIES' named entity 'WEANING' named entity 'MCS' named entity 'EXCLUDED' named entity 'RATE' named entity 'VAD' named entity 'poster session' named entity 'IRB' named entity 'centrifugal pump' named entity 'statistical significance' named entity 'ECMO' named entity 'central venous pressure' named entity 'VAD' named entity 'renal dysfunction' named entity 'chi-squared test' named entity 'medical treatment' named entity 'base excess' named entity 'ECMO' named entity 'LVAD' named entity 'left atrium' named entity 'Clinical features' named entity 'pharmaceutical' named entity 'ACT' named entity 'LVAD' named entity 'heart transplantation' named entity 'pediatric patients' named entity 'follow-up' named entity 'mmHg' named entity 'pleural effusions' named entity 'cardiac dysfunction' named entity 'hepatic dysfunction' named entity 'transfusion' named entity 'body weight' named entity 'started' named entity 'temporary' named entity 'features' named entity 'dilated cardiomyopathy' named entity 'ECMO' named entity 'multivariate analysis' named entity 'LVAD' named entity 'hemoglobin' named entity 'plasma' named entity 'VAD' named entity '8 days' named entity 'left atrial appendage' named entity 'RBC' named entity 'Germany' named entity 'statistically significant' named entity 'VAD' named entity 'hemolysis' named entity 'Renal impairment' named entity 'pediatric patients' named entity 'ECMO'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software